Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 3
2008 3
2009 3
2010 5
2011 5
2012 1
2013 3
2015 1
2016 3
2017 3
2018 3
2019 4
2020 4
2021 6
2022 5
2023 5
2024 3
2025 4
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapies.
Miyake-Stoner SJ, Maine CJ, Chou AC, Dailey GP, Spasova DS, Domingo CC, Sparks J, Picarda G, Lyerly HK, Crosby EJ, Geall AJ, Wang NS, Hartman ZC, Aliahmad P. Miyake-Stoner SJ, et al. Among authors: hartman zc. Mol Ther. 2026 Mar 25:S1525-0016(26)00212-1. doi: 10.1016/j.ymthe.2026.03.026. Online ahead of print. Mol Ther. 2026. PMID: 41889175 Free PMC article.
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity.
Hwang BJ, Crosby EJ, Severson DT, Trotter TN, McBane J, Tsao LC, Wang T, Liu CX, Yang XY, Lei G, Wei J, Ma X, Liu B, Hobeika A, Morse M, Joseph J, Agritelley E, Kanu E, Comatas K, Keler T, He LZ, Lyerly HK, Hartman ZC. Hwang BJ, et al. Among authors: hartman zc. Sci Immunol. 2025 Dec 19;10(114):eadz2294. doi: 10.1126/sciimmunol.adz2294. Epub 2025 Dec 19. Sci Immunol. 2025. PMID: 41417923
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer.
Tinoco JC, Saunders HI, Werner LR, Sun X, Chowanec EI, Heard A, Chalise P, Vahrenkamp JM, Wilson AE, Liu CX, Lei G, Wei J, Cros H, Mohammed H, Troester M, Perou C, Markiewicz MA, Gertz J, Balko JM, Hartman ZC, Hagan CR. Tinoco JC, et al. Among authors: hartman zc. J Immunother Cancer. 2025 Mar 18;13(3):e010179. doi: 10.1136/jitc-2024-010179. J Immunother Cancer. 2025. PMID: 40102028 Free PMC article.
63 results